The Everstone Group has invested US$35 million in India’ OmniActive Health Technologies Ltd (OmniActive) ttwin labs calcium citrate with magnesiumo accelerate its growth in the nutraceuticals space. ###The deal is Everstone’s third in the healthcare and wellness sector in less than a year.###OmniActive provides naturally sourced ingredients for eye health, weight management and heart health to global nutraceutical companies that offer food supplements and nutritional fortification. ###It has a research-driven approach, manufacturing facilities, research and debluebonnet calcium magnesium vitamin d3velopment centers across India and Canada, and sales and marketing presence across the US, Europe and Asia.###In the last 18 months, innovation-driven OmniActive completed 12 human clinical trials in healthy populations across its portfolio of branded ingredients.###The company has a strong presence in the US and is working to achieve similar success in Europe and Asia. ###The Everstone investment — which gives it a significant minority stake — will help OmniActive diversify and expand its offerings.###OmniActive will use the proceeds from this deal in its inorganic growth strategy and execute the acquisition opportunities it has identified.###The global nutraceuticals supplements market was estimated at US$108 billion in 2014 and is expected to reach US$168 billion by 2020. ###The US is the largest market, accounting for slightly more than one-third of global sales. ###In India, according to a study published by the Associated Chambers of Commerce of India, the nutraceuticals industry is expected to reach US$6.1 billion by 2020. ###The growth in India will be fueled by rising awareness about lifestyle diseases and the need for healthier lifestyles; the spread of urbanization; azinc citrate 50 mg solaraynl carnitine magnesium citrate increasing middle-citracal d3 maximum plusclass population with a higher disposable income; and the rising demand for supplementary nutrition for a healthier life.